Dr. Sabbatini on Novel Approaches With IP Therapy For Ovarian Cancer

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

Dr. Sabbatini on Promising Therapies in Newly Diagnosed Ovarian CancerПодробнее

Treatment ovarian cancer with novel targeted therapies and IOПодробнее

Dr. Sabbatini on Frontline Treatment of Newly Diagnosed Ovarian CancerПодробнее

Dr. Sabbatini on the Future of Dose-Dense Therapy in Ovarian CancerПодробнее

Stanford's Dr. Oliver Dorigo on Ovarian Cancer -- Current & Novel Treatment StrategiesПодробнее

Ovarian Cancer – An Introduction, with Dr. Paul SabbatiniПодробнее

Novel Therapeutics in Ovarian Cancer: What to WatchПодробнее

Treatments for Recurrent Ovarian CancerПодробнее

Using Novel Therapies in Advanced Ovarian CancerПодробнее

Bringing change with TTFields therapy in ovarian cancerПодробнее

Novel Immunotherapy Targets Recurrent Ovarian CancerПодробнее

Dr. Salani on Choosing Among IV, IP, and Dose-Dense Chemo Regimens in Ovarian CancerПодробнее

Novel Agents and the Future Treatment of Ovarian CancerПодробнее

Novel therapies and combinations in ovarian cancerПодробнее

Novel Therapies for Newly Diagnosed Advanced Ovarian CancerПодробнее

Emerging Novel Agents for Ovarian CancerПодробнее

New Ovarian Cancer Research and Treatments | Memorial Sloan KetteringПодробнее

Dr. Zamarin on Novel Immunotherapy Approaches in Gynecologic CancersПодробнее